Isotretinoin Gel 0.05% vs 0.1%: What Is Sold?

Verdict: For isotretinoin gel strengths 0.05% vs 0.1%, 0.05% has the clearest gel evidence. A higher number is not proven better. I found no acne trial directly comparing 0.05% gel with 0.1% gel. The clearest direct cream trial found no statistically significant efficacy difference. A 0.1% gel has no proven advantage. Neither is a self-selected option. Current regulator checks found no live single-ingredient gel in the US, UK, Canada, or South Korea.

Isotretinoin gel 0.05% vs 0.1% at a glance

Evidence and product status checked on 12 November 2026

Decision point	Isotretinoin 0.05%	Isotretinoin 0.1%
Amount in each gram	0.5 mg/g	1 mg/g
Gel evidence for acne	A 268-person controlled trial found 0.05% gel beat its vehicle over 14 weeks.	No comparable 0.1% gel trial was found.
Direct strength comparison	Two small trials included 0.05% and 0.1% creams, not gels. The 2000 trial found no statistically significant difference. The 1994 abstract did not establish 0.1% as better.
Irritation evidence	Two people left the 0.05% gel trial because of irritation.	In one cream trial, three skin events occurred in two people using 0.1%.
Current status in checked markets	Not currently available in the UK or Canada. A South Korean export-only licence was withdrawn in 2024. No US topical label was found.	A South Korean export-only licence was withdrawn in 2024. No US, UK, or Canadian product was confirmed.
Prescription status	Former Canadian and South Korean products were prescription medicines.	The withdrawn South Korean export product was a prescription medicine.
Pregnancy	Topical retinoids are contraindicated during pregnancy and when planning pregnancy. The Korean labels carried the same warning.

The practical answer is simple. Don't choose 0.1% because it contains twice as much drug. The evidence doesn't show that this produces better acne clearance, and you may not have a current approved product to choose.

What the direct comparisons actually tested

Langner and colleagues ran the closest head-to-head trial in 2000. It included 127 people with mild to moderate facial acne. They used 0.05% cream, 0.1% cream, or a placebo cream for 12 weeks.

Both active creams improved inflammatory and non-inflammatory acne more than placebo. The two strengths did not differ statistically. Three skin-related events occurred in two people, both in the 0.1% group. They resolved without stopping treatment.

An earlier 1994 trial enrolled 82 people and also compared both creams with placebo. Both strengths reduced acne grades over 12 weeks. Good or excellent tolerance was reported by 73.1% using 0.05% and 79.2% using 0.1%.

That result doesn't prove equal safety. The groups were small, and the trial wasn't built to establish equivalence. It also doesn't answer the gel question because a cream base changes delivery and irritation.

NICE's 2021 evidence review flagged limits in the 2000 study. Allocation concealment wasn't reported, and protocol deviations affected every group. These old trials support activity, but they don't establish a winner.

What we know about 0.05% gel

Chalker and colleagues tested 0.05% gel against its vehicle in 268 people who completed a 14-week study. All had mild to moderate acne. The gel reduced inflammatory lesions more than vehicle after five weeks. Differences in clogged lesions and acne grade appeared after eight weeks.

Two people left because of irritation. That matters because redness, peeling, burning, and dryness can limit topical retinoid use. More product doesn't clear acne faster.

This trial shows that 0.05% gel can work. It doesn't show that 0.1% gel works better, because no 0.1% group existed. Separate studies never create a head-to-head result.

Which topical isotretinoin strengths are actually sold?

Online listings often outlive licences. We checked official databases instead, with the following results current on 12 November 2026.

• United Kingdom: The NHS record marks isotretinoin 0.05% gel as unavailable since March 2017. A current regional NHS formulary also says Isotrex was discontinued in 2017.
• Canada: Health Canada lists prescription Isotrex 0.05% gel as “Cancelled Post Market” since May 2005.
• South Korea: The regulator lists prescription 0.05% and 0.1% gels as export-only products. Both licences were withdrawn on 2 April 2024.
• United States: The current DailyMed search returned oral isotretinoin capsules, not a topical isotretinoin gel label.

This is a scoped check, not a claim about every country. A national licence also doesn't guarantee local pharmacy stock. Ask for the active ingredient, strength, formulation, licence status, and prescription requirement where you live.

Check the name before comparing percentages

Topical isotretinoin, oral isotretinoin, and tretinoin are different products. The familiar Accutane name refers to oral isotretinoin. It treats severe or resistant acne under close medical supervision.

Tretinoin is a different retinoid. Its creams commonly use percentages such as 0.025%, 0.05%, or 0.1%. Adapalene gel also commonly appears as 0.1%. A search for “isotretinoin gel 0.1” can therefore lead to the wrong drug.

If your tube says tretinoin, use our tretinoin strength comparison. The topical isotretinoin versus tretinoin guide explains why the names aren't interchangeable.

How to make the decision safely

1. Read the active ingredient. Confirm whether the tube contains isotretinoin, tretinoin, adapalene, or a combination.
2. Check the formulation. Evidence from a cream cannot predict the same effect from a gel.
3. Check local approval. A prescriber or pharmacist can confirm whether that exact product is licensed and supplied.
4. Set a realistic review point. The 0.05% gel trial separated from vehicle after five to eight weeks, not days.
5. Report troublesome irritation. Burning, marked redness, cracking, or persistent peeling needs professional advice, not a stronger tube.

The 2024 American Academy of Dermatology guideline strongly recommends topical retinoids as a class. It doesn't establish 0.1% topical isotretinoin gel as the best choice. Modern acne care often combines treatments with different actions, chosen around severity and tolerance.

Pregnant people and those planning pregnancy should not use topical retinoids. The European Medicines Agency applies this precaution despite low systemic absorption. Don't start, stop, or switch a prescription without the prescriber.

See a dermatologist for deep painful nodules, scarring, marked distress, or acne that persists after a proper treatment course. The cystic acne referral guide explains which signs make waiting a poor choice.